The authors studied the efficacy and safety of combined venlafaxine and quetiapine treatment for treatment-resistant depression (TRD) by dividing 95 TRD patients into two treatment groups: a combined venlafaxine (225 mg/day) and quetiapine (400 mg/day) group and a venlafaxine-only (225 mg/day) group for 8 weeks. Efficacy was assessed with the Hamilton Rating Scale for Depression, 17 items (Ham-D-17) and the Hamilton Rating Scale for Anxiety (Ham-A); safety was assessed with the Treatment-Emergent Symptom Scale (TESS). The two groups showed significant differences for the Ham-D-17 and Ham-A and no differences on the TESS. Combined venlafaxine and quetiapine treatment showed good efficacy and safety in TRD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1176/appi.neuropsych.12070171 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Risk of congenital anomalies associated with psychotropic medications: a review of neonatal reports in the FDA adverse event reporting System (FAERS).
Arch Womens Ment Health
December 2024
College of Pharmacy, Jinan University, Guangzhou, Guangdong, China.
Purpose: This study investigates the potential association between commonly prescribed psychotropic medications, such as Atypical Antipsychotics (AAs), Selective Serotonin Reuptake Inhibitors (SSRIs), and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs), and congenital anomalies in newborns. The analysis uses data from the Food and Drug Administration Adverse Event Reporting System (FAERS).
Methods: Spontaneously reported cases of congenital anomalies in newborns (under 28 days old) were extracted from the FAERS database, covering January 2004 to June 2023.
The use of prescription medication and other drugs by New Zealand drivers with illegal blood alcohol levels.
Traffic Inj Prev
November 2024
Forensic Specialised Analytical Services (F-SAS), Institute of Environmental Science and Research (ESR), Wellington, New Zealand.
Objective: This study examined the prevalence of the use of prescription medicines and other drugs by a selected subgroup of New Zealand drivers. The use of potentially impairing prescription drugs by the driving population is largely unknown. The population studied was drivers who were stopped by police, failed a breath alcohol test, elected to provide a blood sample for laboratory analysis, and had blood alcohol levels exceeding the legal limit.
View Article and Find Full Text PDFEffects of age, sex, daily dose, comorbidity and co-medication on venlafaxine-associated cardiovascular adverse events: A pharmacovigilance analysis of the FDA Adverse Event Reporting System database.
Br J Clin Pharmacol
October 2024
The Affiliated Brain Hospital, Guangzhou Medical University, 36 Mingxin Road, Guangzhou, China.
Article Synopsis
- This study investigated cardiovascular adverse events (AEs) linked to venlafaxine (VEN) therapy by analyzing data from the FDA Adverse Event Reporting System between January 2004 and December 2023.
- It revealed that higher doses of VEN increased the risk of various cardiovascular issues, especially in older adults, males, and those with other medical conditions or taking certain medications.
- The findings suggest close monitoring of cardiovascular health in elderly patients on VEN and highlight the need for further prospective research to confirm these results.
A Proposed Algorithm for the Pharmacological Treatment of Generalized Anxiety Disorder in the Older Patient.
J Geriatr Psychiatry Neurol
October 2024
Psychiatry Department, VA Boston Healthcare System, Brockton, MA, USA.
Article Synopsis
- A new algorithm from Harvard focuses on treating generalized anxiety disorder (GAD) specifically in older adults, reviewing relevant studies to determine medication effectiveness.
- Selective serotonin reuptake inhibitors (SSRIs), especially sertraline and escitalopram, are recommended as the first-line treatments, with alternatives like buspirone suggested for minimizing sexual side effects.
- If initial treatments don’t work, other options include different SSRIs, SNRIs, and medications like pregabalin or gabapentin, while caution is advised with benzodiazepines and hydroxyzine due to potential risks in elderly patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!